Health Condition 1: T560- Toxic effects of lead and its compounds
Conditions
Interventions
Intervention1: Atasi Ghana: 2 capsules of 500mg of Atasi ghana, at bed time for 4 weeks will be given.
Control Intervention1: Triphala churna
Dadima svarasa: 5g of TriphalÄ? curna early in the morning
Sponsors
ITRA Jamnagar Gujrat India
Eligibility
Inclusion criteria
Inclusion criteria: Workers willing to participate in the study The workers who are working in lead based industries since 3 months Age between 18 to 70 years.
Exclusion criteria
Exclusion criteria: The workers having uncontrolled systemic disease condition hypertension (Systolic/diastolic above 140/90 mmHg), diabetes (RBS 200mg/dl) etc. The workers having life threatening diseases like renal, heart and liver failure etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune Status (ISQ score) The Immune Status Questionnaire (ISQ) will be used to assess the immune status. The ISQ consists of 7 items (common cold, diarrhea, sudden high fever, headache, muscle and joint pain, skin problems and coughing). â?¢ Change in sign and symptoms associated to Occupational health hazards (baseline and end of the treatment) Timepoint: 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Respiratory function (Pulmonary function test) (baseline and end of the treatment). Safety trial CBC, liver function (ALT, AST) kidney function (Serum creatinine) analysis (baseline and end of the treatment). Timepoint: 1 month | — |
Countries
India
Contacts
Public ContactKajal V Radadiya
ITRA jamnagar
Outcome results
None listed